Advertisement

Topics

Elorac to Present Data from Its Novel Treatment For Nodulocystic Acne at the Annual Society For Investigative Dermatology Meeting

08:56 EDT 17 May 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Elorac, Inc., a biopharmaceutical company focused on developing first-in-class and best-in-class innovative dermatology products, today announced that data from its Phase 2 trial evaluating the safety and efficacy of its patente...

Other Sources for this Article

Elorac, Inc.
Barry Hollingsworth
847-362-8200 ext. 230
barry@eloracpharma.com

NEXT ARTICLE

More From BioPortfolio on "Elorac to Present Data from Its Novel Treatment For Nodulocystic Acne at the Annual Society For Investigative Dermatology Meeting"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Acne
Acne is a common skin condition that causes spots to develop on the skin, usually on the face, back and chest..  The spots can range from blackheads and whiteheads which are often mild, to inflamed pus-filled pustules and cysts, which can be severe ...